Evolent Health (EVH) Gross Margin (2015 - 2026)

Evolent Health has reported Gross Margin for 12 years, with the latest figure at 12.39% in Q2 2026.

• On a quarterly basis, Gross Margin fell 1020.0% year-over-year to 12.39% in Q2 2026; TTM through Jun 2026 was 17.25%, a 88.0% increase from a year earlier, with the FY2025 full-year figure at 21.31%, up 693.0% from the prior year.
• Gross Margin was 12.39% for Q2 2026 at Evolent Health, down from 16.88% in the prior quarter.
• The five-year high for Gross Margin was 27.41% in Q1 2023, with the low at 11.71% in Q4 2024.
• Average Gross Margin over 5 years is 20.07%, with a median of 21.0% recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Gross Margin sank 1205 bps in 2022, then soared 904 bps in 2025.
• Over 5 years, Gross Margin stood at 21.72% in 2022, then dropped by 16 bps to 18.28% in 2023, then sank by 36 bps to 11.71% in 2024, then jumped by 77 bps to 20.75% in 2025, then tumbled by 40 bps to 12.39% in 2026.
• The last three Gross Margin figures came in at 12.39% (Q2 2026), 16.88% (Q1 2026), and 20.75% (Q4 2025), per Business Quant data.